CPRX - CATALYST PHARMACEUTICALS, INC.
24.69
0.770 3.119%
Share volume: 1,026,073
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$23.92
0.77
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-25-2026 | |
| Total revenue | 98.509 M | 122.710 M | 128.695 M | 141.820 M | 141.421 M | 146.563 M | 148.392 M | 152.613 M | |
| Cost of revenue | 12.520 M | 15.405 M | 19.277 M | 21.643 M | 17.911 M | 20.614 M | 22.654 M | 26.074 M | |
| Gross profit | 85.989 M | 107.305 M | 109.418 M | 120.177 M | 123.510 M | 125.949 M | 125.738 M | 126.539 M | |
| 24.79% | 1.97% | 9.83% | 2.77% | 1.97% | -0.17% | 0.64% | |||
| Operating expenses | 49.519 M | 43.715 M | 49.164 M | 47.990 M | 50.798 M | 50.307 M | 50.127 M | 55.228 M | |
| Selling general and admin | 46.938 M | 40.730 M | 45.880 M | 44.192 M | 46.911 M | 45.949 M | 47.470 M | 53.421 M | |
| Research and development | 2.581 M | 2.985 M | 3.284 M | 3.798 M | 3.887 M | 4.358 M | 2.657 M | 1.807 M | |
| Total expenses | 58.863 M | 53.059 M | 58.509 M | 57.334 M | 60.143 M | 59.651 M | 59.471 M | 64.693 M | |
| -9.86% | 10.27% | -2.01% | 4.90% | -0.82% | -0.30% | 8.78% | |||
| Operating income | 27.126 M | 54.246 M | 50.909 M | 62.843 M | 63.367 M | 66.298 M | 66.267 M | 61.846 M | |
| Ebit | 29.089 M | 55.788 M | 57.205 M | 74.181 M | 71.286 M | 69.293 M | 71.035 M | 71.901 M | |
| Pretax income | 29.089 M | 55.788 M | 57.205 M | 74.181 M | 71.286 M | 69.293 M | 71.035 M | 71.901 M | |
| 91.78% | 2.54% | 29.68% | -3.90% | -2.80% | 2.51% | 1.22% | |||
| Income tax | 5.814 M | 14.994 M | 13.321 M | 18.245 M | 14.549 M | 17.185 M | 18.252 M | 19.203 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 23.275 M | 40.794 M | 43.884 M | 55.936 M | 56.737 M | 52.108 M | 52.783 M | 52.698 M | |
| 75.27% | 7.57% | 27.46% | 1.43% | -8.16% | 1.30% | -0.16% |